Literature DB >> 20801146

Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy.

Hille W van Dijk1, Frank D Verbraak, Marilette Stehouwer, Pauline H B Kok, Mona K Garvin, Milan Sonka, J Hans DeVries, Reinier O Schlingemann, Michael D Abràmoff.   

Abstract

Diabetic retinopathy (DR) classically presents with micro-aneurysms, small haemorrhages and/or lipoprotein exudates. Several studies have indicated that neural loss occurs in DR even before vascular damage can be observed. This study evaluated the possible relationship between structure (spectral domain-optical coherence tomography) and function (Rarebit visual field test) in patients with type 1 diabetes mellitus and no or minimal diabetic retinopathy (DR). Results demonstrated loss of macular visual function and corresponding thinning of the ganglion cell layer (GCL) in the pericentral area of the macula of diabetic patients (Rs = 0.65, p < 0.001). In multivariable logistic regression analysis, GCL thickness remained an independent predictor of decreased visual function (OR 1.5, 95% CI 1.1-2.1). Early DR seems to include a neurodegenerative component.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20801146      PMCID: PMC3017636          DOI: 10.1016/j.visres.2010.08.024

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  46 in total

Review 1.  The fundamental plan of the retina.

Authors:  R H Masland
Journal:  Nat Neurosci       Date:  2001-09       Impact factor: 24.884

2.  Structure and function in glaucoma: The relationship between a functional visual field map and an anatomic retinal map.

Authors:  Nicholas G Strouthidis; Veronica Vinciotti; Allan J Tucker; Stuart K Gardiner; David P Crabb; David F Garway-Heath
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-12       Impact factor: 4.799

3.  Rarebit perimetry in normal subjects: test-retest variability, learning effect, normative range, influence of optical defocus, and cataract extraction.

Authors:  Maria Letizia Salvetat; Marco Zeppieri; Lucia Parisi; Paolo Brusini
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-11       Impact factor: 4.799

Review 4.  A framework for comparing structural and functional measures of glaucomatous damage.

Authors:  Donald C Hood; Randy H Kardon
Journal:  Prog Retin Eye Res       Date:  2007-08-21       Impact factor: 21.198

5.  Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons.

Authors:  L A Kerrigan-Baumrind; H A Quigley; M E Pease; D F Kerrigan; R S Mitchell
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-03       Impact factor: 4.799

6.  Glial reactivity, an early feature of diabetic retinopathy.

Authors:  E Rungger-Brändle; A A Dosso; P M Leuenberger
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-06       Impact factor: 4.799

7.  Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes.

Authors:  Hille W van Dijk; Frank D Verbraak; Pauline H B Kok; Mona K Garvin; Milan Sonka; Kyungmoo Lee; J Hans Devries; Robert P J Michels; Mirjam E J van Velthoven; Reinier O Schlingemann; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-03       Impact factor: 4.799

8.  Local diabetic retinopathy prediction by multifocal ERG delays over 3 years.

Authors:  Jason S Ng; Marcus A Bearse; Marilyn E Schneck; Shirin Barez; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

9.  Early detection of macular changes in patients with diabetes using Rarebit Fovea Test and optical coherence tomography.

Authors:  M Nilsson; G von Wendt; P Wanger; L Martin
Journal:  Br J Ophthalmol       Date:  2007-06-25       Impact factor: 4.638

10.  The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema.

Authors:  David J Browning; Christina M Fraser; Stephen Clark
Journal:  Ophthalmology       Date:  2007-12-11       Impact factor: 12.079

View more
  44 in total

Review 1.  Diabetic retinopathy is a neurodegenerative disorder.

Authors:  Stephanie K Lynch; Michael D Abràmoff
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

Review 2.  Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.

Authors:  Sidra Zafar; Mira Sachdeva; Benjamin J Frankfort; Roomasa Channa
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

3.  Intravitreal Fluocinolone Acetonide May Decelerate Diabetic Retinal Neurodegeneration.

Authors:  Stephanie K Lynch; Kyungmoo Lee; Zhi Chen; James C Folk; Ursula Schmidt-Erfurth; Bianca S Gerendas; Andreas Wahle; Charles C Wykoff; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-05-01       Impact factor: 4.799

4.  Early neurodegeneration in the retina of type 2 diabetic patients.

Authors:  Hille W van Dijk; Frank D Verbraak; Pauline H B Kok; Marilette Stehouwer; Mona K Garvin; Milan Sonka; J Hans DeVries; Reinier O Schlingemann; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-14       Impact factor: 4.799

5.  Role of ganglion cell complex in visual recovery following surgical internal limiting membrane peeling.

Authors:  Luisa Pierro; Lorenzo Iuliano; Marco Gagliardi; Marco Codenotti; Alessandro Ambrosi; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-23       Impact factor: 3.117

Review 6.  Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.

Authors:  S Priya Narayanan; Esraa Shosha; Chithra D Palani
Journal:  Pharmacol Res       Date:  2019-06-15       Impact factor: 7.658

7.  Evaluation of optic disc, retinal nerve fiber and macular ganglion cell layers in pediatric diabetes.

Authors:  Evre Pekel; Selda Ayça Altıncık; Gökhan Pekel
Journal:  Int Ophthalmol       Date:  2017-08-05       Impact factor: 2.031

8.  Cone Photoreceptor Dysfunction in Early-Stage Diabetic Retinopathy: Association Between the Activation Phase of Cone Phototransduction and the Flicker Electroretinogram.

Authors:  J Jason McAnany; Jason C Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-01-02       Impact factor: 4.799

9.  Insulin treatment normalizes retinal neuroinflammation but not markers of synapse loss in diabetic rats.

Authors:  Dustin R Masser; Heather D VanGuilder Starkey; Georgina V Bixler; Wendy Dunton; Sarah K Bronson; Willard M Freeman
Journal:  Exp Eye Res       Date:  2014-06-12       Impact factor: 3.467

10.  Association of Diabetic Macular Nonperfusion With Outer Retinal Disruption on Optical Coherence Tomography.

Authors:  Fabio Scarinci; Lee M Jampol; Robert A Linsenmeier; Amani A Fawzi
Journal:  JAMA Ophthalmol       Date:  2015-09       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.